Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zai Lab (ZLAB) Total Liabilities (2018 - 2025)

Historic Total Liabilities for Zai Lab (ZLAB) over the last 8 years, with Q3 2025 value amounting to $399.0 million.

  • Zai Lab's Total Liabilities rose 2559.77% to $399.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $399.0 million, marking a year-over-year increase of 2559.77%. This contributed to the annual value of $344.9 million for FY2024, which is 4358.37% up from last year.
  • Latest data reveals that Zai Lab reported Total Liabilities of $399.0 million as of Q3 2025, which was up 2559.77% from $372.4 million recorded in Q2 2025.
  • Zai Lab's Total Liabilities' 5-year high stood at $399.0 million during Q3 2025, with a 5-year trough of $121.6 million in Q1 2021.
  • Its 5-year average for Total Liabilities is $238.6 million, with a median of $223.5 million in 2021.
  • Its Total Liabilities has fluctuated over the past 5 years, first surged by 17011.77% in 2021, then crashed by 2411.09% in 2022.
  • Quarter analysis of 5 years shows Zai Lab's Total Liabilities stood at $230.0 million in 2021, then dropped by 24.11% to $174.5 million in 2022, then skyrocketed by 37.6% to $240.2 million in 2023, then soared by 43.58% to $344.9 million in 2024, then increased by 15.7% to $399.0 million in 2025.
  • Its Total Liabilities stands at $399.0 million for Q3 2025, versus $372.4 million for Q2 2025 and $362.6 million for Q1 2025.